Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

University of Pennslyvania, Philadelphia

Levine Cancer Institute, Charlotte

H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa

Ohio State Medical Center, Columbus

Oncology Hematology Care, Inc., Cincinnati

Medical College of Wisconsin, Milwaukee

Northwestern University-NMDTI, Chicago

Regional Care Cancer Centers NJ, Morristown

University of California Los Angeles, Santa Monica

UC Davis Cancer Center, Sacramento

Seattle Cancer Center Alliance, Seattle

Yale Cancer Center, New Haven

Dana-Farber / Harvard Cancer Institute, Boston

Dana Farber Cancer Institute, Boston

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack